D&K - John LaBrie, 42, HPV cancer in left tonsil and lymph node, Springfield with Dr. Glenn Hanna, Head & Neck Program, Dana-Farber 8-21-18
John initially went to the doctor in May 2017 to treat what he thought was strep throat. Multiple doctor visits revealed a larger issue and John was diagnosed with HPV cancer of his left tonsil and lymph node region.
After his diagnosis, John underwent rounds of chemotherapy and radiation. However, he has now completed his treatment.
Dr. Hanna completed his residency training in internal medicine at Beth Israel Deaconess Medical Center and fellowship training in hematology & medical oncology at the Dana-Farber Cancer Institute in 2016.
Dr. Hanna’s research focuses on understanding mechanisms of response and resistance to immunotherapies in head and neck cancer.
The American Thyroid Association has awarded a 2017 Research Grant, funded by the Thyroid Cancer Survivors’ Association, Inc. to Dr. Hanna to open a phase II study of the effect of two combined immune-checkpoint inhibitors on advanced thyroid cancer.
John initially chose Dana-Farber for his care because of its affiliations and its reputation for excellent care in the area.
In his spare time, John loves to golf and run. This year, he will be running the Boston Marathon to raise money for Dana-Farber under the charity “Golf Fights Cancer.”
Throughout his treatment, John has been supported by his wife, Cheryl, and their four kids.
Dr. Hanna completed his residency training in internal medicine at Beth Israel Deaconess Medical Center and fellowship training in hematology & medical oncology at the Dana-Farber Cancer Institute in 2016.
Dr. Hanna’s research focuses on understanding mechanisms of response and resistance to immunotherapies in head and neck cancer.
The American Thyroid Association has awarded a 2017 Research Grant, funded by the Thyroid Cancer Survivors’ Association, Inc. to Dr. Hanna to open a phase II study of the effect of two combined immune-checkpoint inhibitors on advanced thyroid cancer.